Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection
Abstract Background Epidemiologic data suggest that patients with systemic lupus erythematosus (SLE) have a lower risk of breast cancer than women in the general population. In light of mechanistic studies suggesting that anti-DNA antibodies have anti-cancer effects, we sought to examine breast canc...
Main Authors: | Ami A. Shah, Takeru Igusa, Daniel Goldman, Jessica Li, Livia Casciola-Rosen, Antony Rosen, Michelle Petri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-021-02449-3 |
Similar Items
-
Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus
by: Hwee Siew Howe, et al.
Published: (2019-12-01) -
Cognitive functions and autoantibodies in patients with systemic lupus erythematosus
by: Anna Bogaczewicz, et al.
Published: (2016-06-01) -
Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus
by: Miao Shao, et al.
Published: (2018-01-01) -
Autoantibodies in pediatric systemic lupus erythematosus: Cluster analysis and its clinical implications in Indian children
by: Siva Vyasam, et al.
Published: (2023-01-01) -
Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus
by: Jessica S. Kleer, et al.
Published: (2022-01-01)